A1CARE HBA1C
Mexico·Clase I·III. DIAGNOSTIC AGENTS·AXMILAB, S.A. DE C.V.·Registered June 17, 2022LASOLUCIÓNDECONTROLA1CAREHBA1CESTÁDISEÑADAPARA SERUTILIZADA COMOMATERIAL DE CONTROL DECALIDAD PARA CONTROLAR EL RENDIMIENTO Y LAPRECISIÓN DE LOS MÉTODOS DE DETERMINACIÓN DEHEMOGLOBINA A1C.
LASOLUCIÓNDECONTROLA1CAREHBA1CESTÁDISEÑADAPARA BE USED AS QUALITY CONTROL MATERIAL TO MONITOR THE PERFORMANCE AND ACCURACY OF HEMOGLOBIN A1C DETERMINATION METHODS.
- Risk Class / Clase de Riesgo
- Clase I
- Product Type (Spanish)
- III. AGENTES DE DIAGNÓSTICO
- Product Type (English)
- III. DIAGNOSTIC AGENTS
- Trade Name (Spanish)
- SOLUCIÓN DE CONTROL
- Trade Name (English)
- CONTROL SOLUTION
- Analysis ID
- 510R2022 SSA
- Registration Date
- June 17, 2022
- Name (Spanish)
- AXMILAB, S.A. DE C.V.
- Name (English)
- AXMILAB, S.A. DE C.V.
Access comprehensive regulatory information for A1CARE HBA1C (A1CARE HBA1C) in the Mexico medical device market through Pure Global AI's free database. This Clase I medical device is registered under COFEPRIS analysis ID 510R2022 SSA and manufactured by AXMILAB, S.A. DE C.V.. The device was registered on June 17, 2022.
This page provides complete registration details including product type (III. DIAGNOSTIC AGENTS), manufacturer information, and regulatory compliance data from the official Mexico COFEPRIS medical device database. Pure Global AI offers free access to Mexico's complete medical device registry with bilingual Spanish/English support, helping global MedTech companies navigate COFEPRIS regulations efficiently.